Exact Mass: 307.1296

Exact Mass Matches: 307.1296

Found 168 metabolites which its exact mass value is equals to given mass value 307.1296, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Cusparine

2-[2-(1,3-benzodioxol-5-yl)ethyl]-4-methoxy-quinoline

C19H17NO3 (307.1208)


   

Rutacridone

1,11-dihydro-5-Hydroxy-11-methyl-2-(1-methylethenyl)furo[2,3-c]acridin-6(2H)-one

C19H17NO3 (307.1208)


Rutacridone is found in herbs and spices. Rutacridone is an alkaloid from Ruta graveolens (rue). Alkaloid from Ruta graveolens (rue). Rutacridone is found in herbs and spices.

   

2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one

2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one

C19H17NO3 (307.1208)


C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor D004791 - Enzyme Inhibitors

   

N-Acetylanonaine

1-{3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-yl}ethan-1-one

C19H17NO3 (307.1208)


N-Acetylanonaine is found in fruits. N-Acetylanonaine is an alkaloid from the root bark of Zanthoxylum simulans (Szechuan pepper

   

1,N2-propanodeoxyguanosine

3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H,4H,6H,7H,8H,10H-pyrimido[1,2-a]purin-10-one

C13H17N5O4 (307.128)


1,N2-propanodeoxyguanosine belongs to the family of Purine 2-deoxyribonucleosides and Analogues. These are compounds consisting of a purine linked to a ribose which lacks an hydroxyl group at position 2.

   

6-(7-Hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl)-N-methyl-2-naphthamide

6-{7-hydroxy-5H,6H,7H-pyrrolo[1,2-c]imidazol-7-yl}-N-methylnaphthalene-2-carboxamide

C18H17N3O2 (307.1321)


   

Carbocysteine-lysine

6-Amino-2-[[2-amino-3-(carboxymethylsulfanyl)propanoyl]amino]hexanoic acid

C11H21N3O5S (307.1202)


   

Fabomotizole

5-ethoxy-2-{[2-(morpholin-4-yl)ethyl]sulfanyl}-1H-1,3-benzodiazole

C15H21N3O2S (307.1354)


C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics

   

Dehydroisolaureline

Dehydroisolaureline

C19H17NO3 (307.1208)


   
   

Furanoclausamine B

(-)-Furanoclausamine B

C19H17NO3 (307.1208)


   

Noracronycine

Noracronycine

C19H17NO3 (307.1208)


   

Dehydrostephalagine

Dehydrostephalagine

C19H17NO3 (307.1208)


   
   

Dehydrostephanine

1,2-Methylenedioxy-8-methoxydehydroaporphine

C19H17NO3 (307.1208)


   

Des-N-methylacronycine

Des-N-methylacronycine

C19H17NO3 (307.1208)


   

7-Methoxymurrayacine

7-Methoxymurrayacine

C19H17NO3 (307.1208)


A natural product found in Clausena harmandiana.

   

2-Cyclohex-3-enyl-6-[(3-methoxypropyl)amino]-4-oxo-3,4-dihydro-2H-1,3-thiazine-5-carbonitrile

2-Cyclohex-3-enyl-6-[(3-methoxypropyl)amino]-4-oxo-3,4-dihydro-2H-1,3-thiazine-5-carbonitrile

C15H21N3O2S (307.1354)


   

Maybridge3_004861

Maybridge3_004861

C16H21NO3S (307.1242)


   

N4-[5-(2-Phenyleth-1-ynyl)-3-pyridyl]morpholine-4-carboxamide

N4-[5-(2-Phenyleth-1-ynyl)-3-pyridyl]morpholine-4-carboxamide

C18H17N3O2 (307.1321)


   

Maybridge3_006009

Maybridge3_006009

C19H17NO3 (307.1208)


   
   

(Methoxymethyl)triphenylphosphonium

(Methoxymethyl)triphenylphosphonium

C20H20OP+ (307.1252)


   
   

N-Demethyl-N-formyldehydronuciferine

N-Demethyl-N-formyldehydronuciferine

C19H17NO3 (307.1208)


   

Mafaicheenamine E

Mafaicheenamine E

C19H17NO3 (307.1208)


   
   

Claulansine F

Claulansine F

C19H17NO3 (307.1208)


   

clauraila C

clauraila C

C19H17NO3 (307.1208)


A natural product found in Clausena harmandiana.

   

2-isopropenyl-5-methoxy-1,11-dihydro-2H-furo[2,3-c]acridin-6-one|Rutacridon

2-isopropenyl-5-methoxy-1,11-dihydro-2H-furo[2,3-c]acridin-6-one|Rutacridon

C19H17NO3 (307.1208)


   

Antibiotic A 53868A

Antibiotic A 53868A

C11H22N3O5P (307.1297)


   
   
   
   

2鈥樎?3鈥樎?O-Isopropylidene-Adenosine

2鈥樎?3鈥樎?O-Isopropylidene-Adenosine

C13H17N5O4 (307.128)


   

7,8-dehydro-1-hydroxyrutaecarpine

7,8-dehydro-1-hydroxyrutaecarpine

C18H17N3O2 (307.1321)


   
   
   
   
   

(S)-2-((S)-2-((S)-2-Amino-4-(methylthio)butanamido)propanamido)-3-hydroxypropanoic acid

(S)-2-((S)-2-((S)-2-Amino-4-(methylthio)butanamido)propanamido)-3-hydroxypropanoic acid

C11H21N3O5S (307.1202)


   
   
   
   
   
   
   

Apoatropine HCl

8-Methyl-8-azabicyclo[3.2.1]octan-3-yl 2-phenylprop-2-enoate--hydrogen chloride (1/1)

C17H22ClNO2 (307.1339)


   

N-Allyladenosine

2-(6-Allylamino-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol

C13H17N5O4 (307.128)


relative retention time with respect to 9-anthracene Carboxylic Acid is 0.520 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.523 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.516 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.518

   

(Methoxymethyl)triphenylphosphonium

(Methoxymethyl)triphenylphosphonium

[C20H20OP]+ (307.1252)


CONFIDENCE standard compound; INTERNAL_ID 2485

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

N-Acetylanonaine

1-{3,5-dioxa-11-azapentacyclo[10.7.1.0^{2,6}.0^{8,20}.0^{14,19}]icosa-1(20),2(6),7,14(19),15,17-hexaen-11-yl}ethan-1-one

C19H17NO3 (307.1208)


   

Didesmethyl Almotriptan

Didesmethyl Almotriptan

C15H21N3O2S (307.1354)


   

Met-Ala-Ser

H-Met-Ala-Ser-OH

C11H21N3O5S (307.1202)


   

(S)-2-(2-Fluoro-benzyl)-3,5-dioxo-pyrrolidine-1-carboxylic acid tert-butyl ester

(S)-2-(2-Fluoro-benzyl)-3,5-dioxo-pyrrolidine-1-carboxylic acid tert-butyl ester

C16H18FNO4 (307.122)


   

1-N-FMOC-3-PYRROLIDINONE

1-N-FMOC-3-PYRROLIDINONE

C19H17NO3 (307.1208)


   

((3AR,4R,6R,6AR)-6-(6-AMINO-9H-PURIN-9-YL)-2,2-DIMETHYLTETRAHYDROFURO[3,4-D][1,3]DIOXOL-4-YL)METHANOL

((3AR,4R,6R,6AR)-6-(6-AMINO-9H-PURIN-9-YL)-2,2-DIMETHYLTETRAHYDROFURO[3,4-D][1,3]DIOXOL-4-YL)METHANOL

C13H17N5O4 (307.128)


   

naphthol as-lt

naphthol as-lt

C19H17NO3 (307.1208)


   

Orteronel

Orteronel

C18H17N3O2 (307.1321)


C471 - Enzyme Inhibitor

   

3-Hydroxy-2-naphthoyl-ortho-phenetidide

3-Hydroxy-2-naphthoyl-ortho-phenetidide

C19H17NO3 (307.1208)


   

Methyl 3-nitro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate

Methyl 3-nitro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate

C14H18BNO6 (307.1227)


   

2-((tert-Butyldimethylsilyloxy)methyl)furo[3,2-b]pyridine-6-carboxylic acid

2-((tert-Butyldimethylsilyloxy)methyl)furo[3,2-b]pyridine-6-carboxylic acid

C15H21NO4Si (307.124)


   

ETHYL1-PHENYL-5-PHENYLAMINOIMIDAZOLE-4-CARBOXYLATE

ETHYL1-PHENYL-5-PHENYLAMINOIMIDAZOLE-4-CARBOXYLATE

C18H17N3O2 (307.1321)


   

ethyl 5-amino-1,4-diphenyl-1H-pyrazole-3-carboxylate

ethyl 5-amino-1,4-diphenyl-1H-pyrazole-3-carboxylate

C18H17N3O2 (307.1321)


   

Pyridine,2,4,6-triphenyl-

Pyridine,2,4,6-triphenyl-

C23H17N (307.1361)


   

6-Fluoro-1-methyl-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid

6-Fluoro-1-methyl-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid

C15H18FN3O3 (307.1332)


   

2,3,4-triphenylpyridine

2,3,4-triphenylpyridine

C23H17N (307.1361)


   

1-Isopropyl-2-acrolein-3-(4-fluorophenyl)-indole

1-Isopropyl-2-acrolein-3-(4-fluorophenyl)-indole

C20H18FNO (307.1372)


   

2,3-O-Isopropylideneadenosine

2,3-O-Isopropylideneadenosine

C13H17N5O4 (307.128)


2',3'-O-Isopropylideneadenosine is an adenosine analog. Adenosine analogs mostly act as smooth muscle vasodilators and have also been shown to inhibit cancer progression. Its popular products are adenosine phosphate, Acadesine (HY-13417), Clofarabine (HY-A0005), Fludarabine phosphate (HY-B0028) and Vidarabine (HY-B0277)[1].

   

N-(Carboxymethyl)-L-cysteine - L-lysine (1:1)

N-(Carboxymethyl)-L-cysteine - L-lysine (1:1)

C11H21N3O5S (307.1202)


   
   

(R)-Ethyl piperidine-3-carboxylate (2R,3R)-2,3-dihydroxysuccinate

(R)-Ethyl piperidine-3-carboxylate (2R,3R)-2,3-dihydroxysuccinate

C12H21NO8 (307.1267)


   

3-hydroxy-7-methoxy-N-(o-tolyl)naphthalene-2-carboxamide

3-hydroxy-7-methoxy-N-(o-tolyl)naphthalene-2-carboxamide

C19H17NO3 (307.1208)


   

(4-cyano-3,5-difluorophenyl) 4-propylcyclohexane-1-carboxylate

(4-cyano-3,5-difluorophenyl) 4-propylcyclohexane-1-carboxylate

C17H19F2NO2 (307.1384)


   

3-(4-nitrophenoxycarbonyl)-2,2,5,5-tetramethyl-1-pyrrolidinyloxy

3-(4-nitrophenoxycarbonyl)-2,2,5,5-tetramethyl-1-pyrrolidinyloxy

C15H19N2O5 (307.1294)


   

3-(3-4-FLUOROPHENYL-1-ISOPROPYL-1H-INDOLE-2-YL) PROPENAL

3-(3-4-FLUOROPHENYL-1-ISOPROPYL-1H-INDOLE-2-YL) PROPENAL

C20H18FNO (307.1372)


   

4-Methoxycarbonyl-2-nitrophenylboronic acid, pinacol ester

4-Methoxycarbonyl-2-nitrophenylboronic acid, pinacol ester

C14H18BNO6 (307.1227)


   

N-(2,4,6-TRIMETHYLPHENYLCARBAMOYLMETHYL)IMINO-DIACETIC ACID,

N-(2,4,6-TRIMETHYLPHENYLCARBAMOYLMETHYL)IMINO-DIACETIC ACID,

C15H19N2O5 (307.1294)


   

N-propionyl-cordycepin

N-propionyl-cordycepin

C13H17N5O4 (307.128)


   

BENZYL 4-OXO-2-PHENYL-3,4-DIHYDROPYRIDINE-1(2H)-CARBOXYLATE

BENZYL 4-OXO-2-PHENYL-3,4-DIHYDROPYRIDINE-1(2H)-CARBOXYLATE

C19H17NO3 (307.1208)


   

Nisoxetine hydrochloride

Nisoxetine hydrochloride

C17H22ClNO2 (307.1339)


   

ETHYL (S)-(-)-NIPECOTATE-D-TARTRATE

ETHYL (S)-(-)-NIPECOTATE-D-TARTRATE

C8H15NO2.C4H6O6 (307.1267)


   

Anitrazafen

Anitrazafen

C18H17N3O2 (307.1321)


C308 - Immunotherapeutic Agent

   

N-(4-Ethoxyphenyl)-3-hydroxy-2-naphthamide

2-Naphthalenecarboxamide, N-(4-ethoxyphenyl)-3-hydroxy-

C19H17NO3 (307.1208)


   

1-[4-(2-chloroethoxy)phenyl]-3,3,4,4,4-pentadeuterio-2-phenylbutan-1-one

1-[4-(2-chloroethoxy)phenyl]-3,3,4,4,4-pentadeuterio-2-phenylbutan-1-one

C18H14ClD5O2 (307.1387)


   

Ethyl (S)-3-Piperidinecarboxylate D-tartrate

Ethyl (S)-3-Piperidinecarboxylate D-tartrate

C12H21NO8 (307.1267)


   

1,N(2)-Propanodeoxyguanosine

1,N(2)-Propanodeoxyguanosine

C13H17N5O4 (307.128)


   

4-{(2E)-2-[(1,2-dimethyl-1H-indol-3-yl)methylidene]hydrazinyl}benzoic acid

4-{(2E)-2-[(1,2-dimethyl-1H-indol-3-yl)methylidene]hydrazinyl}benzoic acid

C18H17N3O2 (307.1321)


   

Carbocysteine-lysine

Carbocysteine-lysine

C11H21N3O5S (307.1202)


   

4-(2,6-Dimethylphenoxy)-5-methoxy-2-(2-pyridinyl)pyrimidine

4-(2,6-Dimethylphenoxy)-5-methoxy-2-(2-pyridinyl)pyrimidine

C18H17N3O2 (307.1321)


   

2-Amino-N,N-Bis(Phenylmethyl)-1,3-Oxazole-5-Carboxamide

2-Amino-N,N-Bis(Phenylmethyl)-1,3-Oxazole-5-Carboxamide

C18H17N3O2 (307.1321)


   

Fabomotizole

Fabomotizole

C15H21N3O2S (307.1354)


C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics

   
   

1-[[(2S)-2-[(2-aminoacetyl)amino]-4-methylpentanoyl]amino]ethenyl-methoxyphosphinic acid

1-[[(2S)-2-[(2-aminoacetyl)amino]-4-methylpentanoyl]amino]ethenyl-methoxyphosphinic acid

C11H22N3O5P (307.1297)


   

3-[(6-Methyl-4-phenyl-2-quinazolinyl)amino]propanoic acid

3-[(6-Methyl-4-phenyl-2-quinazolinyl)amino]propanoic acid

C18H17N3O2 (307.1321)


   

N-[2-(4-methoxyphenyl)ethyl]-2-quinoxalinecarboxamide

N-[2-(4-methoxyphenyl)ethyl]-2-quinoxalinecarboxamide

C18H17N3O2 (307.1321)


   

N-[[(1-oxo-3-phenylpropyl)hydrazo]-sulfanylidenemethyl]pentanamide

N-[[(1-oxo-3-phenylpropyl)hydrazo]-sulfanylidenemethyl]pentanamide

C15H21N3O2S (307.1354)


   

2-(4-methyl-1-oxo-2-phthalazinyl)-N-(4-methylphenyl)acetamide

2-(4-methyl-1-oxo-2-phthalazinyl)-N-(4-methylphenyl)acetamide

C18H17N3O2 (307.1321)


   

1-(4-tert-butylphenoxy)-3-(1H-1,2,4-triazol-5-ylthio)-2-propanol

1-(4-tert-butylphenoxy)-3-(1H-1,2,4-triazol-5-ylthio)-2-propanol

C15H21N3O2S (307.1354)


   

N-[2-(2-phenylphenoxy)ethyl]-2-furancarboxamide

N-[2-(2-phenylphenoxy)ethyl]-2-furancarboxamide

C19H17NO3 (307.1208)


   

1,4-Dioxa-8-azaspiro[4.5]decan-8-yl(4,5,6,7-tetrahydro-1-benzothiophen-2-yl)methanone

1,4-Dioxa-8-azaspiro[4.5]decan-8-yl(4,5,6,7-tetrahydro-1-benzothiophen-2-yl)methanone

C16H21NO3S (307.1242)


   

N-(5-methyl-2-phenyl-3-pyrazolyl)-2-phenoxyacetamide

N-(5-methyl-2-phenyl-3-pyrazolyl)-2-phenoxyacetamide

C18H17N3O2 (307.1321)


   
   
   
   
   
   
   

2-(4-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)phenyl)benzo[d]oxazole

2-(4-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)phenyl)benzo[d]oxazole

C18H18BNO3 (307.138)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

2-amino-7-[4-hydroxy-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-(methylaminomethyl)-3H-pyrrolo[2,3-d]pyrimidin-4-one

2-amino-7-[4-hydroxy-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-(methylaminomethyl)-3H-pyrrolo[2,3-d]pyrimidin-4-one

C13H17N5O4 (307.128)


   

N-Piperoyl-N-methylaniline

N-Piperoyl-N-methylaniline

C19H17NO3 (307.1208)


   

LY 294002

2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one

C19H17NO3 (307.1208)


C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor D004791 - Enzyme Inhibitors

   
   

TAK-700 (Orteronel)

6-(7-Hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl)-N-methyl-2-naphthamide

C18H17N3O2 (307.1321)


   

1A-116

1A-116

C16H16F3N3 (307.1296)


1A-116, a potent Rac1 inhibitor, is specific for W56 residues, can prevent EGF-induced Rac1 activation and block Rac1-P-Rex1 interaction. 1A-116 can induce apoptosis and inhibit cell proliferation, migration and cycle progression in a concentration-dependent manner. 1A-116 also demonstrates a high antimetastatic activity in vivo[1][2][3].

   

15-methoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaene

15-methoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaene

C19H17NO3 (307.1208)


   

(1r)-5-methoxy-1-(2-methylprop-1-en-1-yl)-1h,6h-furo[3,4-c]carbazol-3-one

(1r)-5-methoxy-1-(2-methylprop-1-en-1-yl)-1h,6h-furo[3,4-c]carbazol-3-one

C19H17NO3 (307.1208)


   

15-hydroxy-16-methoxy-8-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,13,15-heptaene-10-carbaldehyde

15-hydroxy-16-methoxy-8-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,13,15-heptaene-10-carbaldehyde

C19H17NO3 (307.1208)


   

10-{[2-(4-hydroxyphenyl)ethyl]amino}-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,7,9-tetraen-11-one

10-{[2-(4-hydroxyphenyl)ethyl]amino}-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,7,9-tetraen-11-one

C18H17N3O2 (307.1321)


   

6-methoxy-2-(prop-1-en-2-yl)-1h,2h,7h-pyrano[3,4-c]carbazol-4-one

6-methoxy-2-(prop-1-en-2-yl)-1h,2h,7h-pyrano[3,4-c]carbazol-4-one

C19H17NO3 (307.1208)


   

16-methoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaene

16-methoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaene

C19H17NO3 (307.1208)


   

10-{[2-(4-hydroxyphenyl)ethyl]amino}-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1,3,8(12),9-tetraen-11-one

10-{[2-(4-hydroxyphenyl)ethyl]amino}-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1,3,8(12),9-tetraen-11-one

C18H17N3O2 (307.1321)


   

(16s)-16-hydroxy-4,14,19-triazatetracyclo[15.3.1.0³,¹¹.0⁵,¹⁰]henicosa-1(20),3(11),5,7,9,17(21),18-heptaen-2-one

(16s)-16-hydroxy-4,14,19-triazatetracyclo[15.3.1.0³,¹¹.0⁵,¹⁰]henicosa-1(20),3(11),5,7,9,17(21),18-heptaen-2-one

C18H17N3O2 (307.1321)


   

(15r,19r,20s)-19-hydroxy-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,11-hexaen-14-one

(15r,19r,20s)-19-hydroxy-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,11-hexaen-14-one

C18H17N3O2 (307.1321)


   

(2r)-6-methoxy-2-(prop-1-en-2-yl)-1h,2h,7h-pyrano[3,4-c]carbazol-4-one

(2r)-6-methoxy-2-(prop-1-en-2-yl)-1h,2h,7h-pyrano[3,4-c]carbazol-4-one

C19H17NO3 (307.1208)


   

11-methoxy-2,2-dimethyl-5h-1-oxa-5-azatetraphen-10-one

11-methoxy-2,2-dimethyl-5h-1-oxa-5-azatetraphen-10-one

C19H17NO3 (307.1208)


   

(2r)-5-hydroxy-11-methyl-2-(prop-1-en-2-yl)-1h,2h-furo[2,3-c]acridin-6-one

(2r)-5-hydroxy-11-methyl-2-(prop-1-en-2-yl)-1h,2h-furo[2,3-c]acridin-6-one

C19H17NO3 (307.1208)


   

(2s)-2-{[(2r)-2-amino-1-hydroxypropylidene]amino}-4-(6-aminopurin-9-yl)butanoic acid

(2s)-2-{[(2r)-2-amino-1-hydroxypropylidene]amino}-4-(6-aminopurin-9-yl)butanoic acid

C12H17N7O3 (307.1393)


   

5-methoxy-1-(2-methylprop-1-en-1-yl)-1h,6h-furo[3,4-c]carbazol-3-one

5-methoxy-1-(2-methylprop-1-en-1-yl)-1h,6h-furo[3,4-c]carbazol-3-one

C19H17NO3 (307.1208)


   

(2s)-5-hydroxy-11-methyl-2-(prop-1-en-2-yl)-1h,2h-furo[2,3-c]acridin-6-one

(2s)-5-hydroxy-11-methyl-2-(prop-1-en-2-yl)-1h,2h-furo[2,3-c]acridin-6-one

C19H17NO3 (307.1208)


   

10-{[2-(4-hydroxyphenyl)ethyl]amino}-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),2,4(12),7,9-pentaen-11-ol

10-{[2-(4-hydroxyphenyl)ethyl]amino}-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),2,4(12),7,9-pentaen-11-ol

C18H17N3O2 (307.1321)


   

16-hydroxy-4,14,19-triazatetracyclo[15.3.1.0³,¹¹.0⁵,¹⁰]henicosa-1(20),3(11),5,7,9,17(21),18-heptaen-2-one

16-hydroxy-4,14,19-triazatetracyclo[15.3.1.0³,¹¹.0⁵,¹⁰]henicosa-1(20),3(11),5,7,9,17(21),18-heptaen-2-one

C18H17N3O2 (307.1321)


   

(3s)-4-methoxy-3-(2-methylprop-1-en-1-yl)-3h,5h-furo[3,4-b]carbazol-1-one

(3s)-4-methoxy-3-(2-methylprop-1-en-1-yl)-3h,5h-furo[3,4-b]carbazol-1-one

C19H17NO3 (307.1208)


   

1-[(12r)-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-yl]ethanone

1-[(12r)-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-yl]ethanone

C19H17NO3 (307.1208)


   

11-hydroxy-2,2,5-trimethyl-1-oxa-5-azatetraphen-10-one

11-hydroxy-2,2,5-trimethyl-1-oxa-5-azatetraphen-10-one

C19H17NO3 (307.1208)


   

19-hydroxy-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,11-hexaen-14-one

19-hydroxy-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,11-hexaen-14-one

C18H17N3O2 (307.1321)